Contraceptives Market (Product - Contraceptive Drugs (Oral Contraceptives (Combined Contraceptives and Mini-pills), Contraceptive Injectable, and Topical Contraceptive Patch) and Contraceptive Devices (Male Contraceptive Devices and Female Contraceptive Devices (Female Condoms, Contraceptive Diaphragms, Contraceptive Sponges, Contraceptive Vaginal Rings, Intrauterine Devices, Sub-dermal Contraceptive Implants, Non-surgical Permanent Contraception Devices)); Distribution Channel - Hospital Pharmacy (Public and Private), Independent Pharmacy, Online Platform, and Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Press Release :
The global contraceptives market is estimated to witness considerable growth over the tenure of assessment due to increased prevalence of unwanted pregnancies across the globe. Contraception, also known as birth control, is made to prevent unwanted pregnancies. Methods of contraception might work in several different ways. One such way is prevention of sperm from fertilizing ovum. Such types of prevention could come in the form of contraceptive sponges, cervical caps, diaphragms, and condoms. Holding the ovaries of women from releasing eggs that could be fertilized, which include use of emergency contraceptive pills, vaginal rings, shots, patches, and birth control pills. Then there are intrauterine devices, which are placed into a woman’s uterus and can be kept for a good many years. Sterilization is another method through which a woman can never get pregnant or it could prevent a man from impregnating a sterilized woman.
The choice of birth control is dependent on several deciding factors, which are the desire to have children, number of sexual partners, frequency to sexual activities, and the health of a person. Based on these factors, a health care practitioner can suggest the best available option.
The global contraceptives market is estimated to rise at a promising rate of growth over the timeframe of analysis due to augmented need for control of population and increased prevalence of sexually transmitted diseases. Implementation of various initiatives that are aimed at bringing down healthcare expenditure related to unwanted pregnancies and rise in the level of awareness about the effects of unwanted pregnancies are estimated to support growth of the global contraceptives market in the years to come.
The global contraceptives market is expected to rise at 6.1% CAGR over the assessment period, 2017 to 2025. It is anticipated that the market value of the global contraceptives market would reach a figure of around US$ 37,242.7 mn by the end of 2025.
The global contraceptives market is regarded as a fragmented one with the presence of many local as well as international players. Some of the prominent players that are profiled in the global contraceptives market comprise Reckitt Benckiser plc, Janssen Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals SA, HLL Lifecare Limited, and Church & Dwight Co., Inc.
Rise in the Incidences of Unwanted Pregnancies to Spur Market Growth
The global contraceptives market is likely to observe growth in the increasing initiatives by governments to raise awareness about adverse effects of population explosion and unwanted pregnancies. Different programs aim to cater to the rising demand for modern contraception methods and provide with sexual and reproductive health services. These health services should comprise participation of young people, adolescents, and women at all phases of evaluation, implementation, and planning. These day many women are delaying their motherhood as career prioritization has taken place amongst many women. More women are increasingly getting aware about the cost of raising a child, increased prevalence about unstable relationships, and worry about job safety. All these factors are likely to propel growth of the global contraceptives market in the years to come.
Some of the major devices of contraception are diaphragms, vaginal implants, intrauterine devices, male and female condoms, sponges, and subdermal implants are some of the main devices and these devices are estimated to account for a large share of the global contraceptives market over the period of assessment. Rise in the awareness level of sexually transmitted disease such as HIV, Gonorrhea, Human Papilloma Virus, Syphilis, and others is expected to drive the demand for contraceptives substantially in the years to come. Benefits of contraceptives are numerous, a case in point is the use of patches, implants, intrauterine devices, and contraceptive pills offer to control menstrual cycle of women. Some of those contraceptives also diminishes the chances of ovarian cysts and uterine cancer, it also assists in the management of endometriosis, makes period less painful and helps in vanishing hormonal acne. Such multiple benefits of contraceptives are likely to bolster growth of the global contraceptives market in the years to come.
Furthermore, rise in the number of gynecologists opting for these devices for the purpose of contraception is estimated to propel growth of the global contraceptives market in the near future. A case in point is Mirena, a hormonal intrauterine device is likely to support growth of the global contraceptives market over the period of analysis.
Contraceptive pills, however, is estimated to dominate the overall contraceptive drugs market due to the presence of a large base of consumers taking them. In addition, various government initiatives and programs to meet the unmet demand of women within the reproductive age bracket are likely to add to the growth of the market in the years to come.
North America to Lead the Market due to Increased Initiatives by Governments
North America is one of the prominent regions in the global contraceptives market and is likely to account for a large chunk of the market over the tenure of assessment. Prevalence of high incidences of abortion together with increased participation of reproductive women in the workforce and very high level of awareness regarding contraceptive products are likely to support growth of the contraceptives market in North America in the years to come. In accordance with the estimates of U.S. Centers for Disease Control and Prevention, in 2011, nearly 45% of all pregnancies were unintended and 75% of all such unintended pregnancies happened to teens in the age group of 15 to 19 years of age. Despite huge amount being spent on the research and development of new technologies the rapid technological progress made, unplanned pregnancy in the US is very high and it has been cause of concern for decades in the region. Government in the US has taken measures to increase the availability of contraceptives through health insurance policies. It has also permitted emergency contraceptives to be made available as Over The Counter (OTC) drugs.
Global Contraceptives Market: Overview
The report on the contraceptive market analyzes the current and future scenario of the global market. Increase in prevalence of unintended pregnancy, advent of new low cost generics drugs and devices of contraceptives by key players, and increase in adoption and awareness for contraceptives usage in developing countries are the major drivers of the global contraceptive market.
The contraceptive market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global contraceptive market with respect to the segments based on product type, distribution channel and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porter’s five forces analysis and value chain analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global contraceptive market.
Global Contraceptives Market: Market Segmentation
Based on product type, the contraceptive market is segmented as contraceptives drugs and contraceptive devices. The contraceptive drug is further segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini-pills. Contraceptive devices is segmented into male contraceptives and female contraceptives. Female contraceptive is segmented into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices, sub-dermal contraceptive implants, and non-surgical permanent contraception devices. The product market segments have been analyzed based on available drugs and devices, product pipeline for new contraceptives products, cost-effectiveness, and preference for contraceptive product among population. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on distribution channel, contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics and others. The market segments have been extensively analyzed based on availability of different contraceptive products, availability of these products at different distribution channels and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Geographically, the global contraceptive market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Global Contraceptives Market: Competitive Landscape
The report also profiles major players in the global contraceptive market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck & Co., Inc., Cipla Inc., Allergan plc, Bayer AG, HLL Lifecare Limited, Mankind Pharma, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Reckitt Benckiser Group plc., and others.
The Global Contraceptives Market is segmented as given below:
by Distribution Channel